VWF and metabolic dysfunction-associated steatotic liver disease: Analyses on hepatic angiogenesis in NAFLD patients are limited in number if compared to those in animal model studies; however, the liver of patients with NAFLD showed increased expression of the endothelial marker von Willebrand factor (vWF), especially in those subjects with advanced fibrosis [28].